ANI Pharmaceuticals, Inc. has announced that its supplemental new drug application for purified Cortrophin Gel (corticotropin) has been accepted by the US Food and Drug Administration for review, with a target action date of 29 October 2021.
“We look forward to further productive engagement with the FDA, and in parallel, we are focused on preparations for the...



